Parsec Financial Management »

Vertex Pharmaceuticals Incorporated shares owned by Parsec Financial Management

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Parsec Financial Management from 13F filings

Historical chart of Parsec Financial Management investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Parsec Financial Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Parsec Financial Management

Quarter filed Position value Share count Share price at filing
2023-03-31 $7.1M 23k 315.07
2022-12-31 $6.5M 23k 288.78
2022-09-30 $5.9M 20k 289.54
2022-06-30 $3.6M 13k 281.76
2022-03-31 $3.2M 12k 260.95
2021-12-31 $1.4M 6.2k 219.56
2021-09-30 $1.2M 6.5k 191.10
2021-06-30 $836k 4.1k 201.54
2021-03-31 $479k 2.2k 215.09

More positions owned by Parsec Financial Management

Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Dimensional Etf Trust Us Core Eqt Mkt (DFAU)
Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p500 Etf (IVV)
Lowe's Companies (LOW)
Ishares Tr Sp Smcp600vl Etf (IJS)
Cisco Systems (CSCO)
BlackRock (BLK)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Ishares Tr Fltg Rate Nt Etf (FLOT)
Novo-nordisk A S Adr (NVO)
Broadcom (AVGO)
Interpublic Group of Companies (IPG)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Parsec Financial Management

Top funds holding Vertex Pharmaceuticals Incorporated

Vanguard Group
BlackRock
FMR
Alliancebernstein
Jpmorgan Chase & Co
Geode Capital Management
Wellington Management Company
Jennison Associates
T. Rowe Price Associates
Amundi
Morgan Stanley
Loomis, Sayles and
Massachusetts Financial Services
Bank of America Corporation
Henderson Group

View all funds holding Vertex Pharmaceuticals Incorporated